Malaria Medicine
Hydroxychloroquine Trials for COVID-19 Suspended by WHO
Sourced from Getty Images. The World Health Organization (WHO) announced that it is pausing clinical trials on the use of the controversial malaria drug, hydroxychloroquine, to treat patients with COVID-19. This was one of four experimental treatments being investigated by the organization and has been under intense scrutiny for some time after it was championed by tech mogul Elon Musk and US President Donald Trump. “The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board,” says Tedros Adhanom Ghebreyesus, WHO director-general, during a press briefing. This “Solidarity trial” is the WHO’s global investigation into experimental treatments for COVID-19 – including hyd...
